Status:
COMPLETED
Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women
Lead Sponsor:
Viramal Limited
Conditions:
Vaginal Atrophy
Eligibility:
FEMALE
45+ years
Brief Summary
The study is designed to determine the effect on vaginal pH and the duration of action measured on the ability of the base formulation to reduce the vaginal pH
Eligibility Criteria
Inclusion
- be greater than 45 years
- no positive findings on screening gynaecological examination
- negative smear test within the last 5 years
Exclusion
- has signs of vaginal infection
- has evidence of alcohol abuse
- has used hormonal replacement therapy in three months prior to study entry
Key Trial Info
Start Date :
November 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 8 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT03770065
Start Date
November 19 2018
End Date
April 8 2020
Last Update
October 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Affiliated Research Center, Inc. (MARC)
Huntsville, Alabama, United States, 35801